Page 340 - Biodegradable Polyesters

318 12 Biodegradable Polyesters Polymer–Polymer Composites

as additional drawing to increase the orientation of PGA molecules which may
improve creep properties. Since PLLA and PGA are condensation polymers
there exists the possibility of transreactions between the fibrils and matrix
which could be leveraged to enhance the interfacial adhesion and subsequently
improve mechanical performance [40, 46, 50]. Clearly many opportunities for
improvement are available to be explored in future work.

References
1. Oxford English Dictionary (2010), Verdouw, P.D. (1990) Arterial stenting
Stent, Oxford University Press. with self-expandable and balloon-
http://www.oxforddictionaries.com/ expandable endoprostheses. Int. J. Card.
definition/english/stent?search Imaging, 5, 163–171.
DictCode=all (accessed 2010) 11. O’Brien, B. and Carroll, W. (2009) The
2. Murray, C.J. and Lopez, A.D. (1997) evolution of cardiovascular stent mate-
Mortality by cause for eight regions of rials and surfaces in response to clinical
theworld:GlobalBurdenofDisease drivers: a review. Acta Biomater., 5,
Study. Lancet, 349, 1269–1276. 945–958.
3. Cardiovascular Media Library (2010) 12. Kastrati, A., Schomig, A., Dirschinger,
http://www.medmovie.com/demo2/. J.,Mehilli,J., vonWelser, N.,Pache,J.,
4. Mani, G., Feldman, M.D., Patel, D., and Schuhlen, H., Schilling, T., Schmitt, C.,
Agrawal, C.M. (2007) Coronary stents: a and Neumann, F.-J. (2000) Increased
materials perspective. Biomaterials, 28, risk of restenosis after placement of
1689–1710. gold-coated stents: results of a random-
5. Hillen, U., Haude, M., Erbel, R., and ized trial comparing gold-coated with
Goos, M. (2002) Evaluation of metal uncoated steel stents in patients with
allergies in patients with coronary stents. coronary artery disease. Circulation, 101,
Contact Dermatitis, 47, 353–356. 2478–2483.
6. Köster,R., Vieluf,D., Kiehn, M., 13. Webster, M.W. and Ormiston, J.A. (2007)
Sommerauer, M., Kahler, J., Baldus, Drug-eluting stents and late stent throm-
S., Meinertz, T., and Hamm, C.W. (2000) bosis. Lancet, 370, 914–915.
Nickel and molybdenum contact aller- 14. Finn, A.V., Joner, M., Nakazawa, G.,
gies in patients with coronary in-stent Kolodgie, F., Newell, J., John, M.C., Gold,
restenosis. Lancet, 356, 1895–1897. H.K., and Virmani, R. (2007) Patholog-
7. Kraitzer, A., Kloog, Y., and Zilberman, ical correlates of late drug-eluting stent
M. (2008) Approaches for prevention of thrombosis: strut coverage as a marker
restenosis. J. Biomed. Mater. Res. - Part B of endothelialization. Circulation, 115,
Appl. Biomater., 85, 583–603. 2435–2441.
8. Serruys, P.W., Kutryk, M.J.B., and Ong, 15. Ormiston, J. and Webster, M. (2007)
A.T.L. (2006) Coronary-artery stents. N. Absorbable coronary stents. Lancet, 369,
Engl. J. Med., 354, 483–495. 1839–1840.
9. Lemesle, G., Delhaye, C., Bonello, L., de 16. Ferrari, E., Benhamou, M., Cerboni, P.,
Labriolle, A., Waksman, R., and Pichard, and Marcel, B. (2005) Coronary syn-
A. (2008) Stent thrombosis in 2008: dromes following aspirin withdrawal: a
definition, predictors, prognosis and special risk for late stent thrombosis. J.
treatment. Arch. Cardiovasc. Dis., 101, Am. Coll. Cardiol., 45, 456–459.
769–777. 17. Grabow, N., Bünger, C.M., Schultze,
10. Van Der Giessen, W.J., Serruys, P.W., C., Schmohl, K., Martin, D.P., Williams,
Van Woerkens, L.J., Beatt, K.J., Visser, S.F., Sternberg, K., and Schmitz, K.P.
W.J., Jongkind, J.F., Van Bremen, R.H., (2007) A biodegradable slotted tube
Ridderhof, E., Van Loon, H., Soei, stent based on poly(l-lactide) and
L.K., Van Beusekom, H.M.M., and poly(4-hydroxybutyrate) for rapid